PerkinElmer Expands Presence In Asia With Acquisition Of SYM-BIO
This article was originally published in The Pink Sheet Daily
Executive Summary
Acquisition of the infectious disease-focused firm provides PerkinElmer infrastructure to access Chinese markets with all of its assays and platforms, including its core prenatal and neonatal products.